MoneyWorks4Me

Bal Pharma informs about audited financial results

06 Aug 2020 Evaluate

In furtherance to submission of Audited Financial Results to the exchanges on 29/07/2020, Bal Pharma has declared that its statutory auditors has issued their audit report on the financial statements of the Company for the financial year ended 31.03.2020, with Un-modified opinion.

The above information is a part of company’s filings submitted to BSE.

Bal Pharma Share Price

85.69 0.00 (0.00%)
17-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1885.05
Dr. Reddys Labs. 1191.05
Cipla 1430.05
Lupin 2250.90
Zydus Lifesciences 1125.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: